Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 45 studies | 58% ± 20% | |
connective tissue cell | 17 studies | 56% ± 24% | |
myofibroblast cell | 12 studies | 50% ± 20% | |
endothelial cell of lymphatic vessel | 9 studies | 30% ± 10% | |
smooth muscle cell | 9 studies | 26% ± 12% | |
endothelial cell | 8 studies | 24% ± 13% | |
pericyte | 8 studies | 23% ± 8% | |
adventitial cell | 5 studies | 68% ± 16% | |
endothelial cell of artery | 4 studies | 49% ± 16% | |
neural crest cell | 3 studies | 26% ± 2% | |
vein endothelial cell | 3 studies | 28% ± 11% | |
extravillous trophoblast | 3 studies | 38% ± 3% | |
capillary endothelial cell | 3 studies | 30% ± 15% | |
retinal cone cell | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 99% | 54085.45 | 454 / 459 | 93% | 350.42 | 1044 / 1118 |
lung | 99% | 42285.40 | 575 / 578 | 91% | 248.38 | 1052 / 1155 |
bladder | 100% | 35541.43 | 21 / 21 | 82% | 230.88 | 414 / 504 |
intestine | 96% | 24933.68 | 928 / 966 | 80% | 216.23 | 423 / 527 |
esophagus | 87% | 24013.80 | 1254 / 1445 | 84% | 213.05 | 154 / 183 |
uterus | 99% | 46769.01 | 169 / 170 | 71% | 223.45 | 324 / 459 |
ovary | 100% | 39912.85 | 180 / 180 | 69% | 155.96 | 298 / 430 |
skin | 98% | 72274.01 | 1776 / 1809 | 67% | 222.07 | 316 / 472 |
stomach | 75% | 16450.30 | 268 / 359 | 84% | 214.60 | 241 / 286 |
thymus | 94% | 18774.20 | 614 / 653 | 56% | 64.99 | 341 / 605 |
prostate | 90% | 18977.65 | 220 / 245 | 58% | 57.79 | 293 / 502 |
pancreas | 18% | 1753.03 | 58 / 328 | 93% | 460.91 | 166 / 178 |
adipose | 100% | 67478.50 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 32653.04 | 1291 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 65% | 7830.69 | 168 / 258 | 30% | 32.18 | 70 / 230 |
heart | 88% | 17357.97 | 761 / 861 | 0% | 0 | 0 / 0 |
kidney | 37% | 5243.79 | 33 / 89 | 30% | 42.66 | 269 / 901 |
tonsil | 0% | 0 | 0 / 0 | 60% | 111.43 | 27 / 45 |
spleen | 59% | 7832.51 | 141 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 45% | 84.42 | 13 / 29 |
brain | 0% | 0 | 0 / 2642 | 36% | 45.33 | 254 / 705 |
eye | 0% | 0 | 0 / 0 | 35% | 37.25 | 28 / 80 |
muscle | 25% | 3283.74 | 197 / 803 | 0% | 0 | 0 / 0 |
liver | 0% | 44.69 | 1 / 226 | 16% | 20.91 | 64 / 406 |
peripheral blood | 0% | 9.40 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042542 | Biological process | response to hydrogen peroxide |
GO_0060346 | Biological process | bone trabecula formation |
GO_1903378 | Biological process | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0001525 | Biological process | angiogenesis |
GO_0048013 | Biological process | ephrin receptor signaling pathway |
GO_0001955 | Biological process | blood vessel maturation |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0043627 | Biological process | response to estrogen |
GO_0001542 | Biological process | ovulation from ovarian follicle |
GO_0071498 | Biological process | cellular response to fluid shear stress |
GO_0001553 | Biological process | luteinization |
GO_0007507 | Biological process | heart development |
GO_0051602 | Biological process | response to electrical stimulus |
GO_0001541 | Biological process | ovarian follicle development |
GO_0001957 | Biological process | intramembranous ossification |
GO_0071392 | Biological process | cellular response to estradiol stimulus |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0007162 | Biological process | negative regulation of cell adhesion |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0022617 | Biological process | extracellular matrix disassembly |
GO_1904645 | Biological process | response to amyloid-beta |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0014012 | Biological process | peripheral nervous system axon regeneration |
GO_0014823 | Biological process | response to activity |
GO_0030574 | Biological process | collagen catabolic process |
GO_0048771 | Biological process | tissue remodeling |
GO_0055093 | Biological process | response to hyperoxia |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0060740 | Biological process | prostate gland epithelium morphogenesis |
GO_0001666 | Biological process | response to hypoxia |
GO_0006508 | Biological process | proteolysis |
GO_0035094 | Biological process | response to nicotine |
GO_0071230 | Biological process | cellular response to amino acid stimulus |
GO_0030163 | Biological process | protein catabolic process |
GO_0019538 | Biological process | protein metabolic process |
GO_0032526 | Biological process | response to retinoic acid |
GO_0045906 | Biological process | negative regulation of vasoconstriction |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0060325 | Biological process | face morphogenesis |
GO_1904707 | Biological process | positive regulation of vascular associated smooth muscle cell proliferation |
GO_0071492 | Biological process | cellular response to UV-A |
GO_0007567 | Biological process | parturition |
GO_0007566 | Biological process | embryo implantation |
GO_0048246 | Biological process | macrophage chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0030017 | Cellular component | sarcomere |
GO_0005634 | Cellular component | nucleus |
GO_0004175 | Molecular function | endopeptidase activity |
GO_0008237 | Molecular function | metallopeptidase activity |
GO_0001968 | Molecular function | fibronectin binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0004222 | Molecular function | metalloendopeptidase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004252 | Molecular function | serine-type endopeptidase activity |
Gene name | MMP2 |
Protein name | 72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX] Matrix metallopeptidase 2 |
Synonyms | CLG4A |
Description | FUNCTION: Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14.; FUNCTION: PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin. Ligand for integrinv/beta3 on the surface of blood vessels.; FUNCTION: [Isoform 2]: Mediates the proteolysis of CHUK/IKKA and initiates a primary innate immune response by inducing mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappaB, NFAT and IRF transcriptional pathways. |
Accessions | ENST00000570283.1 ENST00000568715.5 H3BV48 ENST00000564864.5 ENST00000570308.5 [P08253-2] P08253 ENST00000219070.9 [P08253-1] H3BR66 ENST00000566564.1 ENST00000437642.6 [P08253-3] J3KRB7 H3BS34 ENST00000543485.5 [P08253-2] |